Newsroom

Press Release - Corporate

• 06 Mar 2023
  Agilent to Present at Barclays Global Healthcare Conference
• 28 Feb 2023
  Agilent Reports First-Quarter Fiscal Year 2023 Financial Results
• 22 Feb 2023
  Agilent Announces Cash Dividend of 22.5 Cents Per Share
• 16 Feb 2023
  Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
• 30 Jan 2023
  Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
• 18 Jan 2023
  Agilent Included in Just Capital’s 2023 List of Most Just Companies
• 09 Jan 2023
  Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
• 09 Jan 2023
  Agilent Authorizes $2 Billion Share Repurchase Program
• 04 Jan 2023
  Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
• 16 Dec 2022
  Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences